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A number of mutations in extracellular matrix protein 1 (ECM1) that is a glycoprotein and expressed in 
skin and other tissues are reported to cause a rare, autosomal recessive disorder called lipoid 
proteinosis (LP). The peculiar manifestation of LP is hoarseness of voice caused by laryngeal 
infiltration in infancy. Skin and mucous membrane changes clinically become apparent, and the disease 
typically follows a slowly progressive, yet often benign, course. About 300 cases of LP have been 
reported, but occurrence in siblings is rare. In this study, two siblings (18 and 24-year-old) of a 
Pakistani family were reported to have LP. This study presents two brothers with scaly itchy lesions on 
whole body, hoarse voice and macroglossia. Their deceased father had similar clinical manifestations 
but mother, younger brother and sister were unaffected. Blood from affected and clinically unaffected 
family members were collected with informed consent. The ECM1 gene containing 10 exons were 
amplified and sequenced. Both patients showed non-pathogenic missense and silent mutations in exon 
6 and 8. In exon 6, a nucleotide C was substituted to T (C→T) at codon 2, in patient 1. This non-
pathogenic missense mutation causes appearance of amino acid cysteine instead of arginine that is 
part of normal ECM1 protein. In patient 2, polymorphism of nucleotide C to T (C/T) was observed 
observed in exion 6 that may lead to the appearance of cysteine and/or arginine in the resulting gene 
product. In exon 8, a nucleotide G was substituted to A (G→A) at codon 53, in patient 1. This 
substitution leads to a silent mutation as serine is coded by both forms of codon. In patient 2, 
polymorphism of nucleotide G to A (G/A) was observed in exion 8 that do not cause any change in the 
coded amino acid. These findings represent a set of missense and silent mutations supporting an 
unusual function of ECM1 protein, broadening the spectrum of disease-linked mutations in rare cases 
of LP.  
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Abbreviation: LP, Lipoid proteinosis.
genodermatosis which is characterized by deposition of 
an amorphous hyaline material in skin, mucosa and 
viscera. LP is also known as hyalinosis cutis et mucosae 
or Urbach-Wiethe disease (OMIM: 24700) which was first 
described by Urbach and Weithe (1929). The peculiar 
manifestation of LP is onset in infancy with hoarseness of 
voice caused by laryngeal infiltration. Skin and mucous 
membrane changes clinically become apparent,  and  the  






Figure 1. Family pedigree of the affected and unaffected 
members. Two sons and deceased father are affected, while 




disease typically follows a slowly progressive, yet often 
benign, course. Virtually, any organ may be involved, but 
visceral involvement rarely leads to clinically significant 
consequences. The exceptions are involvement of the 
central nervous system and respiratory tract, which may 
result in seizures and airway obstruction, respectively. 
Lifespan is otherwise normal (Horey et al., 2009; Dyer,  
2008).  
Lipoid proteinosis has been linked to mutations in the 
gene encoding extracellular matrix protein 1 (ECM1). To 
date, no effective treatment is known (Chan et al., 2007). 
The ECM1 protein has important physiological and 
biological roles in epidermal differentiation, binding of 
dermal collagens and proteoglycans, and regulation of 
angiogenesis. The precise function of ECM1 is still 
unknown. Many pathogenic mutations have been 
reported so far, mostly nonsense, missense or splice site 
mutations with the majority occurring in exon 6 or 7 of 
the 10-exon in ECM1 gene encoding a glycoprotein 
(Salih et al., 2011). LP is histologically characterized by 
intercellular deposits of periodic acid Schiff (PAS)-
positive hyaline material in the skin, mucous membranes 
and internal organs. Loss-of-function mutations in the 
gene encoding ECM1 on chromosome 1q21 7 have 
been identified in LP; fewer than 20 variants have been 
reported, that occurred in siblings rarely. 
This study reports an unusual finding of non-pathogenic 
single nucleotide base substitution mutations in exons 6 
and 8 in two brothers of a Pakistani family suffering from 
LP. The results of this study help to understand the 




MATERIALS AND METHODS 
 







Figure 2. Periodic Acid Schiff (PAS)-diastase staining result 
showing deposition of PAS-positive and diastase resistant 
material in skin at the dermal-epidermal junction and 




ethical committee  two  brothers of 18 and 24 years of age suffering  
from LP, from Karachi, Pakistan were selected for this study. Both 
patients were presented with scaly itchy lesions on the whole body, 
hoarse voice and macroglossia. These lesions started at infancy in 
both brothers. Their hoarseness/ and low pitch voice was so severe 
that it was difficult to hear them. On examination, they had eczema, 
with multiple infections and scars on their faces, chest and back. 
Patients were found to have characteristic features of LP such as 
multiple beaded papules along the eyelids, fissured lips and slight 
macroglossia with a hard woody tongue having a homogeneous 
look. According to their mother, her husband had died almost with 
similar skin problem and hoarseness, whereas their younger 
brother and sister were normal (Figure 1).  
Routine investigations (Blood CP, SUCE and LFT) together with 
abdomen USG and CT scan were normal. However, buccal mucosa 
biopsy with PAS stain was suggestive of this condition. Skin 
sections stained with haematoxylin and eosin (H&E) showed 
widespread deposition of hyaline-like material around blood vessels 
and adnexal epithelia, and thickening of the basement membrane 
at the dermal-epidermal junction. On periodic acid-Schiff (PAS) 
staining and PAS-diastase, these sites were PAS positive and 
diastase resistant (Figure 2). 
 
 
Detection of mutation in ECM1 gene 
 
The DNA of the patients and their clinically unaffected family 
members were extracted from peripheral blood by the standard 
phenol-chloroform DNA extraction method (Maniatis et al., 1982). 
Polymerase chain reaction (PCR) amplification of ECM1 gene was 
performed using eight pairs primers (forward and reverse) 
encompassing all 10 exons and situated in flanking introns as 
described earlier (Hamada et al., 2003) and briefly given in Table 1.  
For PCR amplification, the 50 µl PCR reaction volume was used 
containing 1xPCR amplification buffer, 250 ng genomic DNA, 0.6 
mM/each primer, 1.5 mM MgCl2, 0.2 mM/each dNTPs and 2.5 U 
Taq DNA polymerase. The amplification was performed by using 
standard protocol (Hamada et al., 2003; Hougenhouck- Tulleken  et   
al.,  2004). The amplifications were performed at 95°C for 5 min, 
followed by 35 cycles of 95°C  for  45 s,   primer-specific   annealing     




Table 1. Genomic primers used for PCR amplification of ECM1. 
 
ECM1 exon Primer sequence (5'-3') PCR product size (bp) Annealing temperature (°C) 
ECM1-1F  AGCTGGGACTGAAGTCATGGC 
416 62 
ECM1-1R  TAAAGGCTCCACTGGCCTAG 
ECM1-2/3F  TCCTACACTCTTGATCTCCA 
622 59 




ECM1-6F  AGCCTTGAGAAGCAGGAGGA 
671 59 
ECM1-6R  AGTGAACGGGACCTGAGGTT 
ECM1-7F TTATCTGCCTGCCCAGTGTC 
548 59 
ECM1-7R  ACATGGATGGATGGACTGGC 
ECM1-8F  CACATCAACAGTTGCCTCCT 
499 59 
ECM1-8R  GGCATCTTCTGGCATCAGAT 
ECM1-9F AGTTGCCTAGTCCTTCCCCA 
408 60 
ECM1-9R  AGGCCAGGTCAGAGTGAAGA 
ECM1-10F  AATCCAGCTGTGCAAGGCAG 
469 62 


































temperature for 45 s, 60°C for 45 s. PCR products (5 µl) were 
analyzed by 2.5% agarose gel electrophoresis (Figure 3). PCR 
products were then purified by using commercial kit (QIAquick PCR 
Purification Kit, Qiagen, Crawley, UK) and sequenced directly using 
Big Dye® Terminator v3.1 cycle sequencing kit in an ABI 3100 





Direct sequencing of PCR amplified products from the 
affected siblings with LP were shown to have one base 
point mutation by substitution of a nucleotide in exon 6 
and 8. In patient 1, a nucleotide C was substituted to T 
(C→T) as compared to normal control, at codon 2, in 
exon 6 (Figure 4). This non-pathogenic missense 
mutation replaces the of amino acid residue arginine 
(CGC) to cysteine (TGC), unlike the normal ECM1 
protein. In patient 2, at the same location, polymorphism 
of nucleotide C to T (C/T) was observed (Figure 5), which 
may lead to the appearance of cysteine and/or arginine in 
the resulting gene product. 
The sequence analysis of exon 8 in patient 1 and control 
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Figure 4. Sequence analysis of patient 1 showing a nucleotide C substitution to T (C→T) as compared to normal, at codon 2 































  Subjects showed that a nucleotide G was substituted to 
A (G→A) at codon 53, in exon 8 (Figure 6). This substitu-
tion leads to a silent mutation as in both forms of codon 
code for same amino acid residue serine (TCG → TCA). 
In patient 2, at the same location of exon 8, polymorphism 
of nucleotide G to A (G/A) was observed (Figure 7), but 





A number of recent genetic studies reported the 
involvement of homozygous  frame  shift,  missense, non- 
sense and single nucleotide substitution, deletion and 
insertion mutations in ECM1 gene LP which is located on 
chromosome 1q21.2 (Salih et al., 2011; Samdani et al., 
2010; Kumar et al., 2009; Nasir et al., 2009). About 300 
cases of LP have been so far reported. It is found 
worldwide, but is more common in some countries, such 
as South Africa, where a founder effect has been 
demonstrated (Van Hougenhouck-Tulleken et al., 2004). 
The ECM1 has three known splice variants: ECM1a, 
ECM1b and ECM1c. To date, 41 distinct germline 
missense, nonsense, splice site, small and large 
deletions and insertions, have been reported (Chan et al., 
2007). Approximately, 50%  of  the  mutations   cluster  to  



























Figure 6. Sequence analysis of patient 1 and control showing a nucleotide G substitution to A (G→A) at 











Figure 7. Sequence analysis of patient 2 in exon 8 showing polymorphism of nucleotide G to A (G/A) as 




exon 6 and 7 of the gene (Wang et al., 2006). The exact 
pathogenesis of this disease is unknown. It was 
considered either as a lysosomal storage disease or 
disorder of disturbance in collagen synthesis. Recently, 
loss of function mutations in the gene encoding ECM1 on 
band 1q21 has been identified as the cause of lipoid 
proteinosis. The most common location is at exons 6 and 
7, patients with exon 6 mutation result in a more severe 
phenotype, while exon 7 mutations display slightly milder 
clinical features (Kumar et al., 2009).  
This study reports an unusual finding of non-pathogenic 
single nucleotide base substitution mutations in exons 6 
and 8 in two brothers suffering from LP of a Pakistani 
family. The coding region of ECM1 gene containing 10 
exons were amplified and sequenced. Both patients were 
shown to have one base mutation by substitution of a 
nucleotide in exons 6 and 8. In patient 1, a nucleotide C 
was substituted to T (C→T) at codon 2, in exon 6 (Figure 
4). This non-pathogenic missense mutation causes 
conversion of amino acid residue arginine (CGC) to 
cysteine (TGC) unlike the normal ECM1 protein. In 
patient 2, at the same location, polymorphism of 
nucleotide C to T (C/T) was observed (Figure 5), which 
may lead to the appearance of cysteine and/or arginine in 
the resulting gene product. 
The sequence analysis of exon 8 in patient 1 and 
control subjects showed that a nucleotide G was 
substituted to A (G→A) at codon 53, in exon 8  (Figure 6). 




This substitution leads to a silent mutation as in both 
forms of codon code for same amino acid residue, serine 
(TCG → TCA). In patient 2, at the same location of exon 
8, polymorphism of nucleotide G to A (G/A) was observed 
(Figure 6), but this does not cause any change in the 
coded amino acid. Earlier, a case of homozygous 62-bp 
insertion (Nasir et al., 2009) and a case of homozygous 
frame shift mutation leading to premature termination of 
ECM1 protein causing LP (Samdani et al., 2010) have 
been reported in Pakistani families.  
This study presents an unusual missense and silent 
mutations in siblings of Pakistani family suffering from LP. 
These findings support an unusual function of ECM1 
protein and broaden the spectrum of disease-linked 
mutations in this rare case of genodermatosis in this 
region. The identification of these mutations in ECM1 
gene may be of help in making the involvement of ECM1 
gene clear in LP. The results of this study may also be 
exploited to establish a phenotype-genotype correlation, 
more precise and accurate prognosis and/or diagnosis, 
carrier screening for the transfer of LP within families 
horizontally as well as vertically and also in making the 
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